Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin

References

• Endicott JA, Ling V. The biochemistry of P-glycopro-tein-mediated multidrug resistance. Annu Rev Biochem 1989; 58: 137–171.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem 1988; 263 (25): 12163–12166.
   PubMed Web of Science ®Google Scholar
• Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE. P-glycoprotein expression in malignant lym-phoma and reversal of clinical drug resistance with chemother-apy plus high-dose verapamil. J Clin Oncol 1991; 9 (1): 17–24.
   PubMed Web of Science ®Google Scholar
• Raderer M, Scheithauer W. Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer 1993; 72 (12): 3553–3563.
   Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antiox-idants: chemistry, metabolism and structure-activity relation-ships. J Nutr Biochem 2002; 13 (10): 572–584.
   PubMed Web of Science ®Google Scholar
• Phang JM, Poore CM, Lopaczynska J, Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 1993; 53 (24): 5977–5981.
   PubMed Web of Science ®Google Scholar
• Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 1994; 48 (7): 1437–1445.
   PubMed Web of Science ®Google Scholar
• Scambia G, Ranelletti FO, Panici PB et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a pos-sible target. Cancer Chemother Pharmacol 1994; 34 (6): 459-464.
   Google Scholar
• Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 1997; 53 (4): 587–596.
   PubMed Web of Science ®Google Scholar
• Versantvoort CH, Schuurhuis CJ, Pinedo HM et al. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 1993; 68 (5): 939–946.
   PubMed Web of Science ®Google Scholar
• Castro AF, Altenberg GA. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycopro-tein. Biochem Pharmacol 1997; 53 (1): 89–93.
   PubMed Web of Science ®Google Scholar
• Mitsunaga Y, Takanaga H, Matsuo H et al. Effect of bioflavonoids on vincristine transport across blood-brain barri-er. Eur J Pharmacol 2000; 395 (3): 193–201.
   Google Scholar
• Shen DW, Cardarelli C, Hwang J et al. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 1986; 261 (17): 7762–7770.
   Google Scholar
• Ambudkar SV, Lelong IH, Zhang J, Cardarelli CO, Gottesman MM, Pastan I. Partial purification and reconstitu-tion of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 1992; 89 (18);8472-8476.
   Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxici-ty assays. J Immunol Meth 1983; 65(1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Su WC, Chang SL, Chen TY, Chen JS, Tsao CJ. Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. Jpn J Clin Oncol 2000; 30 (12): 562–567.
   PubMed Web of Science ®Google Scholar
• Khantamat O, Chaiwangyen W, Limtrakul P. Screening of flavonoids for their potential inhibitory effect on p-glycopro-tein activity in human cervical carcinoma cells. Chiang Mai Med Bull 2004; 43 (2): 45–56.
   Google Scholar
• Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 1993; 32 (35): 9156–9164.
   PubMed Web of Science ®Google Scholar
• Plouzek CA, Ciolino HP, Clarke R, Yeh GC. Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 1999; 35 (10): 1541–1545.
   PubMed Web of Science ®Google Scholar
• Nakata S, Sato J, Imai K, Yamanaka H, Ichinose Y. Epidemiological characteristics of prostate cancer in Gunma Prefecture, Japan. Gunma University Urological Oncology Study Group. Int J Urol 1995; 2 (3): 191–197.
   PubMedGoogle Scholar
• Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002; 64 (4): 573–582.
   PubMed Web of Science ®Google Scholar
• Low' y OH, Rosebrough NJ, Lewis Farr A, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
   Google Scholar
• Chu TM, Lin TH, Kawinski E. Detection of soluble P-glycoprotein in culture media and extracellular fluid. Biochem Biophys Res Commun 1994; 203: 506–512.
   PubMed Web of Science ®Google Scholar
• Mankhetkorn S, Dubru F, Hesschenbrouck J, Fiallo M, Garnier-Suillerot A. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mol Pharmacol 1996; 49 (3): 532–539.
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Anuchapreeda S, Bhudsuk D. Modulation of human multidrug- resistance MDR-1 gene by natural cur-cuminoids. BMC Cancer 2004; 4 (1): 13–21.
   PubMed Web of Science ®Google Scholar
• Shen DW, Fojo A, Chin JE et al. Human multidrug-resistant cell lines: increased mdrl expression can precede gene amplification. Science 1986; 232 (4750): 643–645.
   PubMed Web of Science ®Google Scholar
• Kioka N, Yamano Y, Komano T, Ueda K. Heat-shock responsive elements in the induction of the multidrug resis-tance gene (MDR1). FESS Lett 1992; 301 (1): 37–40.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Kohno K, Uchiumi T et al. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem Biophys Res Commun 1992; 187 (2): 677-684.
   Google Scholar
• Kim SH, Yeo GS, Lim YS, Kang CD, Kim CM, Chung BS. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp Mol Med 1998; 30 (2): 87–92.
   PubMed Web of Science ®Google Scholar
• Chieli E, Romiti N, Cervelli F, Tongiani R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 1995; 57 (19): 1741–1751.
   PubMed Web of Science ®Google Scholar
• Volm K, Mattern J. Resistance mechanisms and their regulation in lung cancer. Crit Rev Oncogen 1996; 7: 227–244.
   PubMed Web of Science ®Google Scholar
• Dietel M. Whats new in cytostatic drug resistance and pathology. Pathol Res Pract 1991; 187 (7): 892–905.
   PubMed Web of Science ®Google Scholar
• Beck WT. Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoiso-merase II, and other factors. Cancer Treat Rev 1990; 17 Suppl A:11-20.
   Google Scholar
• Morrow CS, Cowan KH. Glutathione S-transferases and drug resistance. Cancer Cells 1990; 2 (1): 15–22.
   PubMed Web of Science ®Google Scholar
• Hammond JR, Johnstone RM, Gros P. Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfect-ed with a full-length complementary DNA clone for the mdrl gene. Cancer Res 1989; 49 (14): 3867–3871.
   PubMed Web of Science ®Google Scholar
• Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89 (6): 1845–1853.
   PubMed Web of Science ®Google Scholar
• Liu YY, Han TY, Giuliano AE, Cabot MC. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 2001; 15 (3): 719–730.
   PubMed Web of Science ®Google Scholar